Description
SAFER Detection™ confirms on-target, off-target and homology-mediated structural rearrangements resulting from gene editing, addressing regulatory expectations for structural rearrangement data, including large deletions, inversions, and chromosomal translocations. It helps mitigate the risk of regulatory filing delays and can enhance the safety profiles of your cell and gene therapy development programs.